Itaú Unibanco Lowers Fee Income Growth Target, Holds Other 2026 Guidance Steady
ITUB sits 35% above its 52-week low of $6.214.
Summary
Itaú Unibanco revised its 2026 guidance, cutting the growth range for fee and insurance income to 2.0%–5.0% from 5.0%–9.0%, while keeping all other targets unchanged. The update follows robust Q2 results and highlights a more cautious view on non-interest revenue.
Key Events · Earnings and Guidance · ITUB
-
Fee Income Growth Outlook Cut
The 2026 guidance for 'Commissions and fees and result from insurance operations' growth has been lowered to 2.0%–5.0% from the previous 5.0%–9.0%, indicating weaker non-interest revenue expectations.
-
Core Lending Targets Unchanged
Total credit portfolio growth (5.5%–9.5%), financial margin with clients (5.0%–9.0%), and cost of credit (R$38.5–R$43.5 billion) are all maintained, signaling stability in the bank's primary operations.
-
Cost of Capital Disclosed
As of August 2026, the company stated it is using a cost of capital of approximately 14.75% p.a. for managing its businesses, providing a benchmark for return expectations.
-
Guidance Update Follows Strong Q2
The revision comes two days after Itaú reported Q2 2026 net income of R$12.4 billion with a 24.3% ROE, suggesting the fee outlook cut is driven not by current earnings weakness but by forward-looking caution.
Analysis · ITUB · Finance
Itaú Unibanco has trimmed its 2026 growth forecast for commissions, fees, and insurance results to 2.0%–5.0%, down from the prior 5.0%–9.0%, signaling emerging pressure on non-interest revenue. All other guidance items—including loan growth, net interest margin, and cost of credit—remain unchanged, suggesting the core lending business is still on track. The revision arrives just days after the bank posted strong Q2 earnings, and the narrower fee outlook may temper full-year expectations.
At the time of this filing, ITUB was trading at $8.41 on NYSE in the Finance sector, with a market capitalization of approximately $92.8B. The 52-week trading range was $6.21 to $9.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.